MIRAE ASSET SECURITIES CO. LTD. Structured Note 2024-12.09.29 (Exp.10.09.29) on Bloomb US P T3 EW N (520078.KQ) Price

MIRAE ASSET SECURITIES CO. LTD. Structured Note 2024-12.09.29 (Exp.10.09.29) on Bloomb US P T3 EW N is offered by Mirae Asset, a leading player in the field of passive investments.

The ISIN of MIRAE ASSET SECURITIES CO. LTD. Structured Note 2024-12.09.29 (Exp.10.09.29) on Bloomb US P T3 EW N is KRG520000784.

European investors may incur additional costs for currency exchange and transaction fees.

No, MIRAE ASSET SECURITIES CO. LTD. Structured Note 2024-12.09.29 (Exp.10.09.29) on Bloomb US P T3 EW N does not comply with the EU UCITS investor protection directives.

MIRAE ASSET SECURITIES CO. LTD. Structured Note 2024-12.09.29 (Exp.10.09.29) on Bloomb US P T3 EW N tracks the performance of the Bloomberg US Pharma Top 3 EW Index - KRW - Benchmark TR Net.

MIRAE ASSET SECURITIES CO. LTD. Structured Note 2024-12.09.29 (Exp.10.09.29) on Bloomb US P T3 EW N is domiciled in KR.

The fund was launched on 9/10/2024.

The MIRAE ASSET SECURITIES CO. LTD. Structured Note 2024-12.09.29 (Exp.10.09.29) on Bloomb US P T3 EW N mainly invests in Healthcare companies.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.